The role of immune infiltrates as prognostic biomarkers in patients with breast cancer
- 30 September 2019
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 68 (10), 1671-1680
- https://doi.org/10.1007/s00262-019-02327-7
Abstract
The presence of immune infiltrates in the tumor microenvironment has been documented in many types of cancer. Moreover, the preexistent or endogenous immunity which consists of interactions between intratumoral lymphocytes and tumor cells is mostly relevant for the successful application of various anticancer therapies, including standard chemotherapy, immune checkpoint inhibition-based immunotherapy and targeted therapies. The immunoscore defines densities of intratumoral immune infiltrates which determine poor or favorable prognosis depending on their quantity and quality in the tumor compartments. Results from large clinical studies have demonstrated an association between high densities of cytotoxic and memory TILs in the tumor compartments with improved prognosis. Importantly, we have demonstrated that differential combined densities of immune infiltrates jointly analyzed in the tumor center (TC) and the invasive margin (IM) have a significant prognostic value in breast cancer patients with poor clinicopathological parameters.This publication has 64 references indexed in Scilit:
- Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanismCancer Immunology, Immunotherapy, 2019
- Immune-based identification of cancer patients at high risk of progressionCurrent Opinion in Immunology, 2018
- Regulation of CTL Infiltration Within the Tumor MicroenvironmentPublished by Springer Science and Business Media LLC ,2017
- The immune contexture in cancer prognosis and treatmentNature Reviews Clinical Oncology, 2017
- Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsetsThe Journal of Experimental Medicine, 2017
- Primary, Adaptive, and Acquired Resistance to Cancer ImmunotherapyCell, 2017
- Tumor Heterogeneity and Tumor Immunity: A Chicken-and-Egg ProblemTrends in Immunology, 2016
- Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant StateVaccines, 2015
- Natural immunity to cancer in humansCurrent Opinion in Immunology, 2010
- The Immunobiology of Cancer Immunosurveillance and ImmunoeditingImmunity, 2004